Streetbeat News

Regulatory

MSFT

Microsoft is investing $2.7 billion in Brazil to develop the AI ecosystem, marking its largest commitment in the country. This move contrasts with Elon Musk's companies facing legal challenges in Brazil.

Portfolio Pulse from Ananya Gairola

September 27, 2024 | 3:04 am

BA

UAL

Boeing 737 Max jets face new safety concerns due to potential jamming of steering pedals caused by moisture leakage. The NTSB has issued recommendations to Boeing and the FAA after an incident involving a United Airlines plane. This adds to the ongoing safety issues with the 737 Max, which was previously grounded after fatal crashes.

Portfolio Pulse from Benzinga Neuro

September 27, 2024 | 2:49 am

BMY

The FDA has approved Bristol-Myers Squibb's Cobenfy, a new antipsychotic drug for schizophrenia that targets cholinergic receptors, marking a shift from the traditional dopamine receptor approach.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:57 pm

NLSP

Trading for a company has been halted at 7:50:00 p.m. ET due to pending news. This could indicate significant upcoming announcements that may impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:50 pm

SEEL

Trading for SEEL has been halted as of 7:50:00 p.m. ET due to pending news. This indicates that significant information regarding the company is expected to be released soon.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 11:50 pm

SAVA

The SEC has charged Cassava Sciences and two former executives for misleading claims about an Alzheimer's clinical trial, resulting in a $40 million civil penalty. The company and executives have agreed to settlements without admitting or denying the allegations.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:56 pm

OVV

Ovintiv has received regulatory approvals to renew its share buy-back program, aligning with its capital allocation strategy to return at least 50% of post-dividend free cash flow to shareholders.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:23 pm

ESTA

Establishment Labs has received FDA approval for its Motiva SmoothSilk Ergonomix and Motiva SmoothSilk Round breast implants, which can now be used in primary and revision breast augmentation procedures.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:22 pm

ALRS

HMNF

Alerus Financial has received all necessary regulatory approvals to complete its acquisition of HMN Financial.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:21 pm

MNTS

Momentus Inc. has received a non-compliance notice from the Nasdaq Listing Qualifications Department, indicating that the company is not meeting certain listing requirements. This could potentially impact the company's stock price and investor confidence.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 9:17 pm